Earkart (BOM:544549) EBIT: ₹48.7 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544549 Earkart Ltd BOM:544549
19 GF Score
Price ₹160.00
! 4 Warning Signs
View Full Analysis

What is Earkart EBIT?

Earkart BOM:544549 19 EBIT is ₹48.7 Mil as of Mar. 2026. GuruFocus rates BOM:544549 with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Earkart's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹48.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹48.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Earkart's annualized ROC % for the quarter that ended in Mar. 2026 was 17.24%. Earkart's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 31.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Earkart's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.45%.

Earkart  (BOM:544549) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Earkart's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=95.678 * ( 1 - 34.63% )/( (265.52 + 460.043)/ 2 )
=62.5447086/362.7815
=17.24 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=302.938 - 33.754 - ( 3.664 - max(0, 102.031 - 269.956+3.664))
=265.52

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=694.919 - 18.009 - ( 216.867 - max(0, 48.681 - 616.81+216.867))
=460.043

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Earkart's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=97.32/( ( (10.035 + max(213.723, 0)) + (51.163 + max(351.286, 0)) )/ 2 )
=97.32/( ( 223.758 + 402.449 )/ 2 )
=97.32/313.1035
=31.08 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(185.681 + 65.496 + 14.984) - (33.754 + 0 + 18.684)
=213.723

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(210.69 + 109.176 + 80.077) - (18.009 + 0 + 30.648)
=351.286

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Earkart's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=48.66/1983.786
=2.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Earkart EBIT Related Terms

Earkart EBIT Historical Data

* Premium members only.

The historical data trend for Earkart's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Earkart EBIT Chart

Earkart Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
1.12 14.61 34.13 94.24 77.98

Earkart Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
EBIT 0.00 0.00 0.00 0.00 48.66

BOM:544549 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Earkart's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Earkart EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Earkart's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Earkart's EV-to-EBIT falls into.


BOM:544549
19GF Score
Earkart Ltd BOM:544549
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earkart EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹48.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹48.7 Mil mean?
Earkart (BOM:544549) has a EBIT of ₹48.7 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Earkart.
Is Earkart's EBIT too high?
Earkart's current EBIT is ₹48.7 Mil. Overall, Earkart has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Earkart's EBIT compare to ABT and SYK?
Earkart's EBIT of ₹48.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Earkart. Earkart's current EBIT is ₹48.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earkart stock overvalued right now?
Earkart (BOM:544549) has a current EBIT of ₹48.7 Mil. The current EBIT is ₹48.7 Mil. Earkart's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Earkart (BOM:544549), the current EBIT is ₹48.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Earkart Business Description

Address Street No. 6, Shop No. 8-P, Vasundhara Enclave, East Delhi, Delhi, IND, 110096
Earkart Ltd is a hearing care company based in India that manufactures and distributes modern hearing aids and related accessories at affordable prices. The company also trades in hearing aids and parts from both Indian and foreign brands. Earkart has expanded its product range to include mobility aids like adjustable foldable walkers and therapy kits for children with disabilities. It developed a remote audiometry machine operated by audiologists to facilitate hearing tests remotely, improving access to hearing care services across India. Earkart operates through a wide network of clinics and hearing solution dispensers, blending manufacturing with a customer-focused approach to reach underserved regions.
19GF Score

Get the complete analysis for BOM:544549

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹160.00
Price